Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$190M |
| 2 |
Lowe's Companies
LOW
|
+$183M |
| 3 |
Target
TGT
|
+$175M |
| 4 |
American Electric Power
AEP
|
+$174M |
| 5 |
NextEra Energy
NEE
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$6.19B |
| 2 |
Coty
COTY
|
+$1.11B |
| 3 |
Apple
AAPL
|
+$294M |
| 4 |
Meta Platforms (Facebook)
META
|
+$229M |
| 5 |
Microsoft
MSFT
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.41% |
| 2 | Financials | 12.33% |
| 3 | Energy | 10.96% |
| 4 | Industrials | 10.38% |
| 5 | Technology | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Granite Construction
GVA
$5.07B
| $29M | 0.06% |
526,460
+423,572
| +412% | +$22.5M |
|
452
AutoNation
AN
$6.76B
| $28.8M | 0.06% |
592,911
+469,920
| +382% | +$21.8M |
|
453
Lennox International
LII
$12.5B
| $28.8M | 0.06% |
187,882
+183,468
| +4,157% | +$28M |
|
454
McCormick & Company Non-Voting
MKC
$13.5B
| $28.7M | 0.06% |
614,860
+494,598
| +411% | +$23.1M |
|
455
Jabil
JBL
$31.1B
| $28.7M | 0.06% |
1,210,715
+693,475
| +134% | +$15.1M |
|
456
Fortune Brands Innovations
FBIN
$4.78B
| $28.6M | 0.06% |
626,959
+93,700
| +18% | +$4.42M |
|
|
ARRS
457
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $28.5M | 0.06% |
946,372
-321,324
| -25% | -$9.32M |
|
458
Rexford Industrial Realty
REXR
$8.66B
| $28.4M | 0.06% |
1,225,738
-65,935
| -5% | -$1.45M |
|
459
Exelixis
EXEL
$14.1B
| $28.3M | 0.06% |
1,899,564
+997,404
| +111% | +$14.4M |
|
|
ALXN
460
DELISTED
Alexion Pharmaceuticals
ALXN
| $28.1M | 0.06% |
229,311
-775,087
| -77% | -$94.8M |
|
461
Rithm Capital
RITM
$5.41B
| $28M | 0.06% |
1,782,900
-146,223
| -8% | -$2.16M |
|
462
Lam Research
LRCX
$337B
| $28M | 0.06% |
2,647,400
-80,550
| -3% | -$818K |
|
463
Waters Corp
WAT
$41B
| $28M | 0.06% |
207,988
+189,865
| +1,048% | +$27.1M |
|
464
Ares Capital
ARCC
$14B
| $27.8M | 0.06% |
1,688,666
-120,669
| -7% | -$1.9M |
|
465
Integra LifeSciences
IART
$1.22B
| $27.7M | 0.06% |
645,902
+505,006
| +358% | +$20.5M |
|
466
Smith & Nephew
SNN
$11.8B
| $27.5M | 0.06% |
914,005
+144,891
| +19% | +$4.26M |
|
|
SPNC
467
DELISTED
Spectranetics Corp
SPNC
| $27.5M | 0.06% |
1,121,614
-113,936
| -9% | -$2.68M |
|
468
Nasdaq
NDAQ
$50B
| $27.4M | 0.06% |
1,224,756
-351,603
| -22% | -$7.76M |
|
469
STAG Industrial
STAG
$7.13B
| $27.4M | 0.06% |
1,147,753
+557,318
| +94% | +$12.8M |
|
|
GWPH
470
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $27.4M | 0.06% |
244,980
+106,642
| +77% | +$12.8M |
|
|
PACW
471
DELISTED
PacWest Bancorp
PACW
| $27.4M | 0.06% |
502,467
+495,681
| +7,304% | +$24M |
|
472
Amphenol
APH
$191B
| $27.2M | 0.06% |
+3,233,160
| New | +$26.9M |
|
|
BPFH
473
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $27M | 0.06% |
1,633,316
+548,248
| +51% | +$7.94M |
|
474
Mettler-Toledo International
MTD
$26.7B
| $27M | 0.06% |
64,500
+58,275
| +936% | +$24.3M |
|
475
Puma Biotechnology
PBYI
$480M
| $26.9M | 0.06% |
875,718
+269,103
| +44% | +$11.6M |
|
Similar funds
Millennium Management's Q4 2016 Portfolio in Review
As of Q4 2016, Millennium Management held 4,092 positions worth $47.8B, down 20% from $59.6B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.
Millennium Management withdrew a net $7.71B in Q4 2016, closing 801 positions and reducing 1,159 holdings. Its most notable exit was Procter & Gamble, an estimated $6.19B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 11% a quarter earlier, followed by Financials and Energy.
Against the trend, Millennium Management opened a new position in Target worth $175M.
- Millennium Management's largest Q4 2016 buy was Target: 2,422,329 shares worth $175M.
- Millennium Management added most to Bank of New York Mellon in Q4 2016, an estimated $190M increase.
- Millennium Management's biggest Q4 2016 reduction was Coty, cutting an estimated $1.11B.
- Millennium Management fully exited Procter & Gamble in Q4 2016, selling an estimated $6.19B.
- Millennium Management's ten largest holdings make up 6.4% of its $47.8B portfolio in Q4 2016.
- Millennium Management opened 858 new positions and closed 801 in Q4 2016.
- Millennium Management's portfolio value fell 20% quarter-over-quarter to $47.8B.
Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.